Emergent BioSolutions (EBS) Depreciation & Amortization (CF) (2010 - 2026)
Emergent BioSolutions (EBS) posted Depreciation & Amortization (CF) of $24.0 million for Q2 2026, up 2.13% on a QoQ basis from $23.5 million in Q1 2026, and up 2.13% year-over-year from $23.5 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $24.0 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 2.13% year-over-year to $24.0 million in Q2 2026; TTM through Jun 2026 was $94.4 million, a 6.81% decrease from a year earlier, with the FY2025 full-year figure at $95.8 million, down 11.95% from the prior year.
- Depreciation & Amortization (CF) was $24.0 million for Q2 2026 at Emergent BioSolutions, up from $23.5 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $44.5 million in Q2 2022, with the low at $23.4 million in Q3 2025.
- Average Depreciation & Amortization (CF) over 5 years is $28.9 million, with a median of $28.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 34.04% in 2022, then retreated 26.07% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $35.7 million in 2022, then slipped by 17.09% to $29.6 million in 2023, then slipped by 12.16% to $26.0 million in 2024, then slipped by 9.62% to $23.5 million in 2025, then increased by 2.13% to $24.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $24.0 million (Q2 2026), $23.5 million (Q1 2026), and $23.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | - |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 1.62 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 594.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 3.97 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 40.52 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 24.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.00 Mn |
| Mar 31, 2026 | 23.50 Mn |
| Dec 31, 2025 | 23.50 Mn |
| Sep 30, 2025 | 23.40 Mn |
| Jun 30, 2025 | 23.50 Mn |
| Mar 31, 2025 | 25.40 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Sep 30, 2024 | 26.40 Mn |
| Jun 30, 2024 | 28.50 Mn |
| Mar 31, 2024 | 27.90 Mn |
| Dec 31, 2023 | 29.60 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 32.90 Mn |
| Mar 31, 2023 | 34.60 Mn |
| Dec 31, 2022 | 35.70 Mn |
| Sep 30, 2022 | 32.20 Mn |
| Jun 30, 2022 | 44.50 Mn |
| Mar 31, 2022 | 30.90 Mn |
| Dec 31, 2021 | 29.20 Mn |
| Sep 30, 2021 | 32.70 Mn |
API Access
Emergent BioSolutions Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();